Vimarsana
Biggest News Aggregation in the World

Page 8 - Clover Assistant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clover Assistant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clover Assistant Today - Breaking & Trending Today

Clover Health Is Down 68% In 1 Year, But Wall Street Is Predicting It'll Rise by 70%. Should You Buy It? - Vimarsana News

Clover Health Is Down 68% In 1 Year, But Wall Street Is Predicting It'll Rise by 70%. Should You Buy It?

Its new focus on profitability might complicate its chances of growth.

Source: fool.com
Insurtech company Clover Health settles remaining lawsuits - Vimarsana News

Insurtech company Clover Health settles remaining lawsuits

The Medicare Advantage insurer allegedly did not disclose active investigations by the Department of Justice to investors when it went public.

Analyzing CVS Health (NYSE:CVS) and Clover Health Investments (NASDAQ:CLOV) - Vimarsana News

Analyzing CVS Health (NYSE:CVS) and Clover Health Investments (NASDAQ:CLOV)

Clover Health Investments (NASDAQ:CLOV – Get Rating) and CVS Health (NYSE:CVS – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Volatility and Risk Clover Health Investments has a beta […]

Short Interest in Clover Health Investments, Corp. (NASDAQ:CLOV) Declines By 5.7% - Vimarsana News

Short Interest in Clover Health Investments, Corp. (NASDAQ:CLOV) Declines By 5.7%

Clover Health Investments, Corp. (NASDAQ:CLOV – Get Rating) was the target of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 37,550,000 shares, a decrease of 5.7% from the April 30th total of 39,820,000 shares. Based on an average daily volume of 6,700,000 shares, […]

Citigroup Trims Clover Health Investments (NASDAQ:CLOV) Target Price to $1.00 - Vimarsana News

Citigroup Trims Clover Health Investments (NASDAQ:CLOV) Target Price to $1.00

Clover Health Investments (NASDAQ:CLOV – Get Rating) had its price objective reduced by Citigroup from $1.30 to $1.00 in a research note issued to investors on Friday, The Fly reports. A number of other brokerages have also commented on CLOV. Canaccord Genuity Group decreased their price target on shares of Clover Health Investments from $4.00 […]